AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA approves Valtrex caplets for reducing risk of spreading herpes.

Women's Health Weekly

| October 02, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 OCT 2 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Valtrex (valacyclovir HCl) caplets for suppressive therapy in otherwise healthy adults with genital herpes to reduce the risk of heterosexual transmission of genital herpes (GH).

The study of 1,484 couples conducted in support of the application showed that once-daily suppressive therapy with Valtrex, in addition to counseling on safer sex practices, reduced the risk of transmission of symptomatic genital herpes (signs or symptoms of GH) by 75% and reduced the risk of overall acquisition of the virus by 48%. Safer sex practices should always be used with suppressive therapy.

"As a physician who's been treating patients suffering with herpes for years, I have consistently heard from my patients that fear of giving this disease to their partner is a major concern. This approval gives patients another tool, in addition to safer sex practices, to help them protect their partners," said Larry Corey, MD, lead study investigator, and professor, laboratory medicine and medicine, University of Washington and head of the Program in Infectious Diseases, Fred Hutchinson Cancer Research Center.

"Now, in addition to safer sex practices, patients with herpes can take once-daily Valtrex to reduce their own outbreaks and, at the same time, protect their partner," Corey said.

While genital herpes is not a life-threatening disease, once infected, the virus never leaves the body, ...

Related articles from newspapers, magazines, journals, and more
Suppressive Therapy Significantly Reduces Genital Outbreaks.(Valtrex for...
Magazine article from: Women's Health Weekly January 17, 2002 700+ words
...recurrent genital herpes with Valtrex caplets for suppressive therapy - treating...outbreaks of genital herpes per year found that suppressive therapy with 500...outbreaks of genital herpes at the first...symptoms. Suppressive therapy means ...
New Study Evaluates Suppressive Therapy With VALTREX(R) Caplets for the...
Press release article from: PR Newswire September 27, 2002 700+ words
...the use of suppressive therapy provides...patients with genital herpes an important...once-daily suppressive therapy with VALTREX...symptomatic genital herpes by 77 percent...symptomatic genital herpes. In addition, suppressive therapy ...
Suppressive Therapy Significantly Reduces Genital Outbreaks.(Brief Article)
Newspaper article from: Virus Weekly January 15, 2002 700+ words
...recurrent genital herpes with Valtrex caplets for suppressive therapy - treating...outbreaks of genital herpes per year found that suppressive therapy with 500...outbreaks of genital herpes at the first...symptoms. Suppressive therapy means ...
Newstream.com Digest: Stopping Car Thefts, New Study Evaluates Valtrex...
Press release article from: Business Wire September 30, 2002 700+ words
...------------- New Study Evaluates Suppressive Therapy With Valtrex(R) Caplets Recent data from the Centers for Disease Control and Prevention (CDC) estimate more...
Suppressive therapy versus episodic therapy with oral valacyclovir for...
Magazine article from: Journal of Drugs in Dermatology Gilbert, Stanley C. April 1, 2007 700+ words
...s efficacy and tolerability as suppressive therapy versus episodic therapy were compared...and 6 months of oral valacyclovir suppressive therapy (1 g once daily) for 6 months...primary endpoint) was lower with suppressive therapy (0.30[+ or -]0.41) than...
Multimedia Available/New Study Evaluates Suppressive Therapy With Valtrex...
Press release article from: Business Wire September 27, 2002 700+ words
Health/Medical Editors ADVISORYfor FRIDAY (Sept. 27) NOTE TO EDITORS: Multimedia Assets Available With This Story Include Logos, Text News Releases, Video BUSINESS WIRE) Recent data from the Centers for Disease Control and Prevention (CDC) estimate more than one million new infections of HSV-2
FDA Approves VALTREX(R) Caplets for Reducing Risk of Spreading Genital Herpes;...
Press release article from: PR Newswire August 29, 2003 700+ words
...caplets for suppressive therapy in otherwise healthy adults with genital herpes in order to...to approve suppressive therapy with VALTREX...transmission of genital herpes in otherwise...once-daily suppressive therapy with VALTREX...symptomatic ...
Landmark Survey Reveals New INSIGHTS into Genital Herpes; Novartis Announces...
Press release article from: PR Newswire March 5, 2003 700+ words
...suppression of recurrent genital herpes in immunocompetent...for initial episode genital herpes infection. The safety...efficacy of Famvir for suppressive therapy have not been established...the transmission of genital herpes. In clinical trials...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA